Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CRSP
Stock Latest News
The Fly
Largest borrow rate increases among liquid names
1d ago
PL
RKT
Premium
Ratings
Promising Developments and Strategic Timing Boost Crispr Therapeutics AG’s Prospects: A Buy Recommendation by Mitchell Kapoor
1d ago
CRSP
Premium
The Fly
Crispr Therapeutics downgraded to Hold from Buy at Clear Street
1d ago
CRSP
Premium
Ratings
Promising Potential and Strategic Positioning Drive Buy Rating for Crispr Therapeutics AG
1d ago
CRSP
Premium
The Fly
Crispr posts strong CTX310 data, says Chardan
2d ago
LLY
CRSP
Premium
Ratings
Buy Rating Affirmed for Crispr Therapeutics AG Due to Promising Clinical Data and Competitive Positioning
2d ago
CRSP
Premium
Ratings
Strategic Alignment and Positive Clinical Data Reinforce Buy Rating for Crispr Therapeutics AG
2d ago
CRSP
Premium
Company Announcements
CRISPR Therapeutics Updates on Cardiovascular Programs
2d ago
8K
CRSP
Premium
The Fly
Crispr announces updates across in vivo cardiovascular disease progams
2d ago
CRSP
Premium
Company Announcements
CRISPR Therapeutics AG Shareholders Approve Key Proposals
19d ago
8K
CRSP
Premium
Weekend Updates
Crispr Therapeutics AG: Stock Soars Amid Bullish Trends
21d ago
CRSP
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
23d ago
CRSP
Premium
Ratings
Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG
25d ago
CRSP
Premium
The Fly
Cathie Wood’s ARK Investment buys 294K shares of Crispr Therapeutics today
30d ago
CRSP
Premium
Market News
Cathie Wood Doubles Down on Nvidia Stock (NVDA) Ahead of Q1 Earnings
1M ago
AMD
CRSP
Premium
The Fly
Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today
1M ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Promising Partnership with Sirius Therapeutics Amidst Clinical and Market Uncertainties Warrants Hold Rating
1M ago
CRSP
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
1M ago
CRSP
Premium
Ratings
Strategic Growth and De-risking: Gil Blum’s Buy Rating on Crispr Therapeutics AG
1M ago
CRSP
Premium
Ratings
Promising Potential of Crispr Therapeutics AG: Buy Rating Backed by Strategic Partnership and Diversified Pipeline
1M ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Strategic Advancements and Growth Potential Drive Buy Rating
1M ago
CRSP
Premium
Ratings
Buy Rating for CRISPR Therapeutics: Strategic Collaboration with Sirius Therapeutics to Enhance Pipeline and Capture Anticoagulant Market Share
1M ago
CRSP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
